Publication | Open Access

Inhaled liposomal ciprofloxacin in patients with non-cystic fibrosis bronchiectasis and chronic lung infection with Pseudomonas aeruginosa (ORBIT-3 and ORBIT-4): two phase 3, randomised controlled trials

Non-cystic Fibrosis BronchiectasisInflammatory Lung DiseaseAntibioticsLung InflammationLiposomal CiprofloxacinAdvanced Lung DiseaseRespiratory InfectionPulmonary FibrosisChronic Lung InfectionPulmonary MedicineMedicineClinical MicrobiologyAntimicrobial ResistancePulmonary Disease